Address
PAC-LINK Management Corp
8 Xingyi Road
20F Shanghai Maxdo Center
Shanghai
31,
China
Website
Recent investment activity
KANDO id: 1704
Corporate information
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 8 of 8Company | Profile | Country | Date Sort ascending | Funding | ||
---|---|---|---|---|---|---|
Revance Therapeutics Inc | Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. | Series D | ||||
DiObex Inc | Biotechnology company that develops novel products for the treatment of metabolic disorders. | Series B | ||||
Portola Pharmaceuticals Inc | N/A | |||||
Epitomics Inc | N/A | |||||
Ascenta Therapeutics Inc | A privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. | N/A | ||||
GlobeImmune Inc | Biopharmaceuticals company. | N/A | ||||
Bayhill Therapeutics | A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. | N/A | ||||
Synacom Technology Inc | N/A |
Team
Employee | Position | |||
---|---|---|---|---|
Irwin Jao | [email protected] | |||
Allen Hsu | ||||
Ming Hsu |